Crohn's Disease
Apr 24, 2008
FDA Approval of Cimzia(R) for Crohn's Disease Represents Latest...
“Cimzia represents another example of the value of Nektar's PEGylation technology and its potential to create important new therapeutics.”
Cimzia is the first and only PEGylated Fab' fragment of a humanized anti-TNF-alpha antibody approved by the FDA. via Rehab Management
Comments
Showing posts
1 - 1 of 1
Showing posts
1 - 1 of 1
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| FDA reviews TNF blockers: Scrutiny may worry so... | Tue | Sebeth | 3 |
| Crohn's & Colitis Foundation Announces Corporat... | Jul 18 | Tammy | 2 |
| Shopping Turns Nightmarish With No Bathroom Access | Jul 17 | Richard | 9 |
| Irvingite running to raise funds for Crohn's di... | Jul 17 | Richard | 1 |
| Dealing with depression with crohn's disease (from May '07) | Jul 16 | Jenn | 8 |
| Individual Health Insurance with Crohn's (from Nov '07) | Jul 1 | Theresa | 5 |
| Pearl Jam Pre-Party To Benefit Patients'-Rights... | Jun 25 | bostonlou | 2 |
Related Topix Forums:
Medicine,
Health,
Science,
Healthcare Industry,
Food and Drug Administration,
Biotech,
Startups,
Chemistry,
Medical Equipment

